Fosun's Ninth CIIE: Guo Guangchang on Bringing Innovation to China and Beyond
Fosun Group showcased its latest innovations at the ninth China International Import Expo (CIIE) in Shanghai on November 5, 2026, featuring the China debut of the Da Vinci 5 surgical robot and new pharmaceutical products. The company, a nine-time CIIE participant, displayed advances in oncology, immunology, and neurodegenerative disease treatments at its Fosun Pharma booth. Chairman Guo Guangchang emphasized converting global innovations into accessible Chinese products while expanding Chinese innovations to international markets. Fosun highlighted achievements including over 1500 CAR-T therapy patients treated, 92 million malaria patients served globally, and multiple drugs approved in over 50 countries. The company plans further international partnerships and strategic signings during the expo.